A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants
Clinical trial NCT05654181 · COMPLETED
Trial details
- NCT number
- NCT05654181
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2023-05-03
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.